SCHEMBL24958739

SCHEMBL24958739

COC(=O)c1cc(C(F)(F)F)ns1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.43
NPC1 O15118 1/20 0.43
NOTUM Q6P988 3/20 0.41
CFTR P13569 2/20 0.39
SMARCA2 P51531 1/20 0.37
SMARCA4 P51532 1/20 0.37
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
POLB P06746 2/20 0.36
GAA P10253 1/20 0.36
SDHB P21912 2/20 0.36
MAPT P10636 1/20 0.36
CSNK2A2 P19784 1/20 0.36
KDR P35968 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12817987 0.83 CSNK2A2 (0.39) PKMNPC1CFTRALDH1A1KDM4E
SCHEMBL24958740 0.82 DAO (0.41) PKMNPC1SMARCA2SMARCA4ALDH1A1
SCHEMBL25183576 0.77 CDK8 (0.37) SMARCA2SMARCA4ALDH1A1KDM4EGAA
SCHEMBL28316078 0.77 CSNK2A2 (0.41) PKMNPC1NOTUMALDH1A1KDM4E
SCHEMBL1912667 0.74 CA12 (0.41) PKMNPC1ALDH1A1KDM4EL3MBTL1
SCHEMBL22367374 0.74 CSNK2A2 (0.42) NPC1ALDH1A1KDM4EL3MBTL1POLB
SCHEMBL19274421 0.73 KDM4E (0.38) NPC1NOTUMALDH1A1KDM4EL3MBTL1
SCHEMBL28315326 0.73 CFTR (0.38) PKMNPC1CFTRALDH1A1KDM4E
SCHEMBL28316585 0.73 KDM4E (0.40) NPC1NOTUMALDH1A1KDM4EL3MBTL1
SCHEMBL24525158 0.72 CFTR (0.52) NOTUMCFTRALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858918-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2024-01-02 US disclosed
US-11858918-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2024-01-02 US disclosed
CN-117295729-A Carboxy-benzimidazole GLP-1R modulating compounds 吉利德科学公司 2023-12-26 CN disclosed
CN-117279905-A Carboxy-benzimidazole GLP-1R modulating compounds 吉利德科学公司 2023-12-22 CN disclosed
EP-4271674-A1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2023-11-08 EP disclosed
EP-4271672-A1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2023-11-08 EP disclosed
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-01-26 US disclosed
WO-2022225941-A1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2022-10-27 WO disclosed
WO-2022225914-A1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2022-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 PKM 2733/4885NPC1 1188/4885NOTUM 3890/4885
US-11858918-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 PKM 2733/4885NPC1 1188/4885NOTUM 3890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.